Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. BB Biotech AG
  6. News
  7. Summary
    BION   CH0038389992

BB BIOTECH AG

(BION)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Bb Biotech Ag Reports Earnings Results for the Second Quarter Ended June 30, 2021

07/23/2021 | 03:13am EDT

BB Biotech AG announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was CHF 144.259 million compared to CHF 1,191.239 million a year ago. Net income was CHF 128.547 million compared to CHF 1,179.660 million a year ago. Basic earnings per share from continuing operations was CHF 2.32 compared to CHF 21.29 a year ago. For the half year, total revenue was CHF 379.817 million compared to CHF 444.759 million a year ago. Net income was CHF 349.495 million compared to CHF 421.706 million a year ago. Basic earnings per share from continuing operations was CHF 6.31 compared to CHF 7.61 a year ago.


ę S&P Capital IQ 2021
All news about BB BIOTECH AG
07/29EQS-ADHOC : Bellevue's bottom-line profit quadruples to CHF 22.5 mn - assets under managem..
DJ
07/23Bb Biotech Ag Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
07/23BB BIOTECH : Posts Lower H1 Profit, Operating Income
MT
07/23BB BIOTECH : Interim report as at June 30, 2021
PU
07/23BB BIOTECH : publishes its interim report
EQ
07/23BB BIOTECH : Solid second quarter for the biotech industry - BB Biotech raised its allocat..
EQ
07/23DGAP-ADHOC : BB Biotech AG pubblica il proprio rapporto intermedio
DJ
07/23DGAP-ADHOC : BB Biotech AG publishes its interim report
DJ
07/23DGAP-NEWS : Il settore delle biotecnologie -2-
DJ
07/23DGAP-NEWS : Il settore delle biotecnologie archivia un secondo trimestre all'insegna della..
DJ
More news
Analyst Recommendations on BB BIOTECH AG
More recommendations
Financials
Sales 2021 - - -
Net income 2021 439 M 476 M 476 M
Net Debt 2021 23,5 M 25,4 M 25,4 M
P/E ratio 2021 8,07x
Yield 2021 4,90%
Capitalization 4 546 M 4 922 M 4 922 M
EV / Sales 2021 -
EV / Sales 2022 -
Nbr of Employees 10
Free-Float 98,2%
Chart BB BIOTECH AG
Duration : Period :
BB Biotech AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BB BIOTECH AG
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 82,05 CHF
Average target price 95,50 CHF
Spread / Average Target 16,4%
EPS Revisions
Managers and Directors
Michael Hutter Head-Finance & Compliance
Erich Hunziker Chairman-Supervisory Board
Daniel Koller Head-Investment Management
Clive A. Meanwell Vice Chairman-Supervisory Board
Thomas von Planta Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BB BIOTECH AG10.65%4 922
MODERNA, INC.210.34%130 866
LONZA GROUP AG26.90%58 060
IQVIA HOLDINGS INC.38.89%47 683
SEAGEN INC.-1.38%31 426
CELLTRION, INC.-38.72%25 414